Paul Schaeffer - Cardiovasc & Metab Therapeut Area, Sanofi R&D

基本信息

Career Trajectory

Bio

Paul Schaeffer worked at Sanofi until 2020. Paul did research in Cancer Research, Cell Biology and Physiology. Paul is now focusing on applying computer software in different areas.

Research Interests

Papers共 92 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure 3 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities

Antoine Alam,Isabelle Blanc,Geneviève Gueguen-Dorbes,Olivier Duclos,Jacques Bonnin,Pauline Barron,Marie-Claude Laplace,Gaelle Morin,Florence Gaujarengues,Frédérique Dol,Jean-Pascal Hérault,Paul Schaeffer,Pierre Savi,Françoise Bono

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 1 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities

openalex（2023）

Cited0Views0Bibtex

Repeatability of biologging data from turtles suggests a new methodology for assessing personality

Cassidy Waldrep,Paul Schaeffer, Adam Parlin, Ann Rypstra

INTEGRATIVE AND COMPARATIVE BIOLOGY (2023): S482-S482

Cited0Views0Bibtex

Supplementary Table 2 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities

openalex（2023）

Cited0Views0Bibtex

Manipulation of photoperiod induces fat storage, but not fat mobilization in a migratory songbird

Paul Schaeffer

INTEGRATIVE AND COMPARATIVE BIOLOGY（2023）

Cited0Views0Bibtex

Supplementary Figure 4 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure Legends 1-4 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities

openalex（2023）

Cited0Views0Bibtex

Supplementary Table 3 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities

openalex（2023）

Cited0Views0Bibtex

Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities

Marie-Laure Ozoux,Veronique Briand,Michel Pelat,Fabrice Barbe,Paul Schaeffer,Philippe Beauverger,Bruno Poirier,Jean-Michel Guillon,Frederic Petit,Jean-Michel Altenburger,Jean-Pierre Bidouard,Philip Janiak

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS（2020）

Cited9Views0WOSBibtex

Thermoregulatory plasticity in Northern Cardinals (1100.13)

Maria Komer,Keely Corder,Paul Schaeffer

The FASEB Journal（2014）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn